Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among Hospitalized Adults Aged ≥60 Years — IVY Network, 20 U.S. States, February 2022–May 2023

Diya Surie, Katharine A. Yuengling, Jennifer DeCuir, Yuwei Zhu, Manjusha Gaglani, Adit A. Ginde, H. Keipp Talbot, Jonathan D. Casey, Nicholas M. Mohr, Shekhar Ghamande, Kevin W. Gibbs, D. Clark Files, David N. Hager, Harith Ali, Matthew E. Prekker, Michelle N. Gong, Amira Mohamed, Nicholas J. Johnson, Jay S. Steingrub, Ithan D. PeltanSamuel M. Brown, Aleda M. Leis, Akram Khan, Catherine L. Hough, William S. Bender, Abhijit Duggal, Jennifer G. Wilson, Nida Qadir, Steven Y. Chang, Christopher Mallow, Jennie H. Kwon, Matthew C. Exline, Adam S. Lauring, Nathan I. Shapiro, Cristie Columbus, Ivana A. Vaughn, Mayur Ramesh, Basmah Safdar, Natasha Halasa, James D. Chappell, Carlos G. Grijalva, Adrienne Baughman, Todd W. Rice, Kelsey N. Womack, Jin H. Han, Sydney A. Swan, Indrani Mukherjee, Nathaniel M. Lewis, Sascha Ellington, Meredith L. McMorrow, Emily T. Martin, Wesley H. Self

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among Hospitalized Adults Aged ≥60 Years — IVY Network, 20 U.S. States, February 2022–May 2023'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences

Social Sciences